LENSAR, Inc. (LNSR) income statement
LNSRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3026% below fair value
$4.46−0.18 (-3.88%)
Close on Nov 20, 2026Market cap $54.80MP/E –Yield –
LENSAR, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 48.3%
- Operating margin
- -13.5%
- Net margin
- 57.6%
- Return on equity, FY2025
- 324.1%
Financial strength
- Current ratio
- 2.39
- Debt to equity
- 0.25
- Debt to assets
- 5.4%
- Cash to current liabilities
- 69.1%
Valuation
- P/E ratio
- –
- Price to sales
- 0.91
- Price to book
- 3.68
- Dividend yield
- –
See a number that looks wrong?